Therapeutic Strategies In Cerabral Ischemia  at Meripustak

Therapeutic Strategies In Cerabral Ischemia

Books from same Author: Liebeskind D S

Books from same Publisher: CLINICAL PUBLISHING

Related Category: Author List / Publisher List

  • Price: ₹ 4719.00/- [ 23.00% off ]

    Seller Price: ₹ 3633.00

Sold By: Store4Doctors      Click for Bulk Order

Offer 1: Get 23.00 % + Flat ₹ 75 discount on shopping of ₹ 500 [Use Code: MPSTK75]

Offer 2: Get 23.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 23.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available

Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Liebeskind D S
    Publish YearMarch 2011


    CLINICAL PUBLISHING Therapeutic Strategies In Cerabral Ischemia by Liebeskind D S

    Despite many recent innovations in therapy, stroke remains one of the greatest challenges in modern medicine, primarily because so few of these new treatments have proved effective. To date, systemic thrombolysis with intravenous tissue plasminogen activator (t-PA) remains the only proven treatment to improve clinical outcomes of patients with acute ischemic stroke. This book reflects on those aspects of these therapies that currently pose potentially formidable challenges to effective treatment or, alternatively, that offer tremendous opportunities for the future. A discussion of arterial revascularization is complemented with coverage of collateral perfusion and the role of the venous system. Fundamentals of supportive care such as hemodynamics and oxygen administration are followed by a reconsideration of neuroprotection in general. The challenges of minor stroke and transient ischemic attacks are considered and hemorrhagic transformation associated with more severe ischemia is also detailed. The importance of early preventive strategies during the subacute phase is also emphasised. Finally, the continuum from animal to clinical research is placed in perspective with a consideration of translational approaches and the use of vascular endpoints in the clinical setting. Each challenge or potential hurdle to advancing therapy more